Revelation Biosciences, Inc.

NASDAQ (USD): Revelation Biosciences, Inc. (REVB)

Last Price

0.647

Today's Change

-0.01 (1.52%)

Day's Change

0.537 - 0.682

Trading Volume

3,923,612

Overview

Market Cap

5 Million

Shares Outstanding

8 Million

Avg Volume

3,002,650

Avg Price (50 Days)

0.65

Avg Price (200 Days)

1.40

PE Ratio

-0.04

EPS

-17.53

Earnings Announcement

20-Mar-2025

Previous Close

0.66

Open

0.64

Day's Range

0.5367 - 0.682

Year Range

0.281 - 25.26

Trading Volume

3,923,612

Price Change Highlight

1 Day Change

-1.52%

5 Day Change

84.33%

1 Month Change

37.72%

3 Month Change

-21.28%

6 Month Change

-62.60%

Ytd Change

-1.52%

1 Year Change

-95.76%

3 Year Change

-99.99%

5 Year Change

-99.99%

10 Year Change

-99.99%

Max Change

-99.99%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment